#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13670	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2177	623.2	0	.	n	.	0	C1450T	SNP	1450	1450	C	1676	1676	T	747	T,C	698,2	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	13670	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2177	623.2	1	SNP	n	C1184T	0	.	.	1184	1184	C	1410	1410	C	759	C	708	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25142	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3560	703.5	0	.	n	.	0	G1337A	SNP	1337	1337	G	1671	1671	A	871	A	815	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25142	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3560	703.5	0	.	n	.	0	T1971C	SNP	1971	1971	T	2305	2305	C	794	C,G	739,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25142	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3560	703.5	1	SNP	n	A2045G	0	.	.	2045	2045	A	2379	2379	A	832	A,T	788,1	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25142	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3560	703.5	1	SNP	n	C2597T	0	.	.	2597	2597	C	2931	2931	C	799	C,T	756,1	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	25142	23S	2890	2890	99.93	23S.l6.c4.ctg.1	3560	703.5	0	HET	.	.	.	G770A	.	770	770	G	1104	1104	G	772	G,A	349,375	.	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1796	folP	855	855	99.88	folP.l15.c17.ctg.1	1495	119.2	1	SNP	p	R229S	1	.	.	685	687	AGC	934	936	AGC	178;175;172	A;G;C	167;164;162	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4882	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3440	141.7	0	.	p	.	0	D95A	NONSYN	283	285	GAC	581	583	GCC	170;171;166	G;C;C	161;163;158	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4882	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3440	141.7	1	SNP	p	S91F	1	.	.	271	273	TTC	569	571	TTC	169;169;168	T;T;C	162;161;161	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1340	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1510	88.3	0	.	p	.	0	A39T	NONSYN	115	117	GCC	656	658	ACC	174;172;172	A;C;C	159;158;158	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1340	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1510	88.3	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	854	856	CAC	171;173;175	C;A;C	161;159;164	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1340	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1510	88.3	0	.	p	.	0	A127fs	FSHIFT	379	379	G	920	920	G	181	G	162	.	.
mtrR.WHO_G_01393	mtrR.WHO_G_01393	1	1	531	1340	mtrR	633	633	99.06	mtrR.l15.c30.ctg.1	1510	88.3	1	SNP	p	G45D	0	.	.	133	135	GGC	674	676	GGC	166;166;166	G;G;C	152;149;149	mtrR.WHO_G_01393:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	776	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	1046	73.8	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4196	parC	2304	2304	99.7	parC.l15.c30.ctg.1	3003	139.1	0	.	p	.	0	S87N	NONSYN	259	261	AGT	574	576	AAT	146;146;145	A;A;T	142;141;140	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4196	parC	2304	2304	99.7	parC.l15.c30.ctg.1	3003	139.1	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1465	1467	GTC	161;162;162	G;T;C,A	151;151;152,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4196	parC	2304	2304	99.7	parC.l15.c30.ctg.1	3003	139.1	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1618	1620	GCA	168;168;168	G;C,T;A,G	156;150,1;151,1	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4196	parC	2304	2304	99.7	parC.l15.c30.ctg.1	3003	139.1	1	SNP	p	D86N	0	.	.	256	258	GAC	571	573	GAC	145;145;143	G;A;C,T	141;140;139,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4196	parC	2304	2304	99.7	parC.l15.c30.ctg.1	3003	139.1	1	SNP	p	S88P	0	.	.	262	264	TCC	577	579	TCC	145;142;145	T,C;C;C	140,1;137;141	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	4026	parE	1986	1986	99.95	parE.l15.c4.ctg.1	2749	145.8	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1556	1558	GGC	175;177;175	G;G;C,A	161;161;157,1	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3618	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	148.9	1	SNP	p	A311V	0	.	.	931	933	GCA	1301	1303	GCA	183;183;186	G,A;C;A	172,1;168;177	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3618	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	148.9	1	SNP	p	I312M	0	.	.	934	936	ATC	1304	1306	ATC	188;190;192	A;T;C	176;175;179	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3618	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	148.9	1	SNP	p	V316P	0	.	.	946	948	GTG	1316	1318	GTG	191;191;191	G;T;G	178;179;181	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3618	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	148.9	1	SNP	p	V316T	0	.	.	946	948	GTG	1316	1318	GTG	191;191;191	G;T;G	178;179;181	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3618	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	148.9	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1820	1822	ACC	173;175;178	A;C;C	156;158;160	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3618	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	148.9	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1874	1876	GCG	168;173;174	G;C;G	157;145;151	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3618	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	148.9	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1874	1876	GCG	168;173;174	G;C;G	157;145;151	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3618	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	148.9	1	SNP	p	G543S	0	.	.	1627	1629	GGT	1997	1999	GGT	148;146;143	G;G;T	136;137;129	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3618	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	148.9	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2006	2008	GGC	142;139;137	G;G;C	129;127;126	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3618	penA	1752	1752	100.0	penA.l15.c4.ctg.1	2419	148.9	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2024	2026	CCG	139;138;138	C,G;C;G	94,1;97;94	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5334	ponA	2397	2397	100.0	ponA.l6.c30.ctg.1	3165	168.0	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1623	1625	CCG	213;214;213	C;C;G,A	186;196;185,2	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	1916	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1886	101.2	0	.	p	.	0	M83fs	FSHIFT	247	247	A	563	563	C	113	C	103	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2958	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1672	175.6	0	.	p	.	0	R143G	NONSYN	427	429	AGA	735	737	GGA	235;237;240	G;G,A;A	225;221,1;225	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2958	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1672	175.6	0	.	p	.	0	.	INDELS	629	630	AA	938	940	TAG	247;247;240	T,A;A;G	230,1;235;227	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2958	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1672	175.6	0	.	p	.	0	.	MULTIPLE	631	633	TAC	942	945	CAAT	237;236;234;237	C,G;A;A;T	222,1;224;221;225	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2958	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1672	175.6	0	.	p	.	0	N212fs	FSHIFT	634	634	A	947	947	T	234	T	224	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2958	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1672	175.6	1	SNP	p	G120K	0	.	.	358	360	GGT	666	668	GGT	211;208;211	G;G,A;T	204;201,1;201	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2958	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1672	175.6	1	SNP	p	A121D	0	.	.	361	363	GCC	669	671	GCC	208;206;206	G,T;C;C	201,1;198;202	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2958	porB1b	1035	1035	98.94	porB1b.l6.c4.ctg.1	1672	175.6	1	SNP	p	A121N	0	.	.	361	363	GCC	669	671	GCC	208;206;206	G,T;C;C	201,1;198;202	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	10944	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4962	220.2	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2028	2030	AAT	253;247;246	A;A;T	241;235;231	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1154	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	1079	106.3	1	SNP	p	V57M	1	.	.	169	171	ATG	524	526	ATG	230;229;225	A;T;G	216;216;214	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	M177T	NONSYN	529	531	ATG	901	903	ACG	468;470;473	A;C;G,T	456;461;461,1	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	922	924	GAC	434;439;440	G;A;C	430;438;438	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	T190M	NONSYN	568	570	ACG	940	942	ATG	406;405;409	A;T;G	405;404;408	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	L194S	NONSYN	580	582	TTA	952	954	TCA	409;407;407	T;C;A	407;407;407	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	997	999	CAG	425;427;425	C;A;G	422;424;423	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1018	1020	CTT	395;390;390	C;T;T	393;386;388	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1039	1041	AGT	405;410;412	A;G;T	399;400;400	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1108	1110	CCG	556;559;559	C;C;G	522;525;525	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1210	1212	TCG	653;655;667	T;C;G	607;605;617	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1381	1383	AAA	340;344;341	A;A;A	324;329;326	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1384	1386	AAG	330;325;320	A;A;G	317;313;306	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1399	1401	CAC	266;261;262	C;A;C	264;255;258	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1438	1440	GAA	274;273;272	G;A;A	272;270;271	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1516	1518	ACG	207;204;202	A,C;C;G	205,1;202;201	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1567	1569	ATT	260;261;265	A;T;T	248;250;253	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1570	1572	AGT	267;264;260	A;G;T	255;254;250	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1609	1611	CTA	298;298;300	C;T;A	280;281;284	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1651	1653	AAT	211;212;211	A;A;T	206;206;206	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1720	1722	TCA	307;304;309	T;C;A	297;293;293	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1744	1746	ATG	333;333;332	A;T;G	322;323;320	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2038	2040	ACC	660;658;659	A;C;C	619;624;624	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	11922	tetM	1920	1920	96.3	tetM.l15.c30.ctg.1	2567	462.1	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2134	2136	GAA	642;643;646	G,T;A;A	611,1;613;615	.	Tetracycline resistance
